Literature DB >> 971456

Toxicity following methoxyflurane anaesthesia. IV. The role of obesity and the effect of low dose anaesthesia on fluoride metabolism and renal function.

P N Samuelson, R G Merin, D R Taves, R B Freeman, J F Calimlim, T Kumazawa.   

Abstract

Seven obese and five normal weight patients were studied before, during and after one hour of methoxyflurane-nitrous oxide anaesthesia during peripheral surgical operations and compared with eight patients of normal weight anaesthetized with nitrous oxide-meperidine and d-tubocurare. Estimates were made of renal function, including serum and urinary electrolytes, osmolarity, uric acid, urea and creatinine. Renal clearances for the latter three substances were also calculated. Serum and urinary inorganic and organic fluoride concentrations were measured, as were renal clearances. This low dose methoxyflurane anaesthesia resulted only in a decrease in uric acid clearance among all the measures, when compared to the meperidine-nitrous oxide controls. The clearance of uric acid remained depressed for longer in the obese patients, but otherwise they did not differ from the normal weight patients. It is possible but not proven that depressed uric acid clearance may be related to the organic fluoride metabolite and an early indicator of methoxyflurane renal toxicity. The previously documented biotransformation of methoxyflurane was seen in this study. A double peak in serum inorganic fluoride was shown in all patients but one. Rather large differences in peak levels of serum inorganic fluoride occurred. The only significant difference between the obese and normal weight patients as far as fluoride metabolism was concerned was a greater variability in the serum inorganic fluoride levels in the obese patients. It would appear that the obese patient metabolizes methoxyflurane in a quantitatively if not qualitatively different fashion than the normal weight patient, perhaps because of fatty infiltration of the liver. Caution is advised in the use of methoxyflurane for more than 90 minutes of low concentration administration in view of the unpredictability of the biotransformation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971456     DOI: 10.1007/BF03005975

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  28 in total

1.  Changes in serum uric acid concentrations after caesarean section using methoxyflurane.

Authors:  W F Hamilton; G S Robertson; D Campbell
Journal:  Br J Anaesth       Date:  1975-04       Impact factor: 9.166

2.  Tetracycline, methoxyflurane anaesthesia, and renal dysfunction.

Authors:  M J Cousins; R I Mazze
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  Renal function after methoxyflurane and halothane anesthesia.

Authors:  R E Tobey; R J Clubb
Journal:  JAMA       Date:  1973-02-05       Impact factor: 56.272

4.  Combined nephrotoxicity of gentamicin and methoxyflurane anaesthesia in man. A case report.

Authors:  R I Mazze; M J Cousins
Journal:  Br J Anaesth       Date:  1973-04       Impact factor: 9.166

5.  Splanchnic circulation in man during methoxyflurane anesthesia.

Authors:  M Libonati; E Malsch; H L Price; L H Cooperman; S Baum; J R Harp
Journal:  Anesthesiology       Date:  1973-05       Impact factor: 7.892

6.  Fluorometabolites of methoxyflurane: serum concentrations and renal clearances.

Authors:  B W Fry; D R Taves; R G Merin
Journal:  Anesthesiology       Date:  1973-01       Impact factor: 7.892

7.  The effects of methoxyflurane anaesthesia and surgery on postoperative renal function in man.

Authors:  T Oyama; K Kimura
Journal:  Anaesthesist       Date:  1972-08       Impact factor: 1.041

8.  Methoxyflurane metabolism and renal dysfunction: clinical correlation in man.

Authors:  R I Mazze; J R Trudell; M J Cousins
Journal:  Anesthesiology       Date:  1971-09       Impact factor: 7.892

9.  Toxicity following methoxyflurane anesthesia. 3. Hemodialysis of metabolites.

Authors:  D R Taves; A J Gillies; R B Freeman; B W Fry
Journal:  JAMA       Date:  1970-10-05       Impact factor: 56.272

10.  Effect of inorganic fluoride on the renal concentrating mechanism. Possible nephrotoxicity in man.

Authors:  J A Frascino
Journal:  J Lab Clin Med       Date:  1972-02
View more
  1 in total

Review 1.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.